$ODC

Oil-Dri (ODC) gets 5.2% ownership disclosure from American Century group

Oil-Dri Corporation of America disclosed that American Century Investment Management (ACIM), American Century Companies (ACC), and the Stowers Institute collectively beneficially own 527,872 shares of Oil-Dri common stock, or 5.2% of the class, as of 06/30/2026, with sole voting and dispositive power reported over the same shares.

Original reporting
Published Aug 14, 2026, 6:50 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 15, 2026, 2:24 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$ODC
Neutral
medium confidence
Mentioned
$ODC
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$ODCNeutralLow
01

Why it matters

For traders, the main signal is ownership concentration and who controls voting and disposition of a 5.2% stake. Without additional actions (tender offer, merger, activism, or guidance), the impact is likely modest.

02

Market read

A fresh 13G filing updates the shareholder map for ODC, but provides no new fundamental catalyst.

03

What to watch

The filing details sole voting and dispositive power, but it does not specify intent, activism, or board influence beyond ownership reporting.

Relevance 4/10Novelty 5/10Timing: ownership disclosure dated 06/30/2026, reported 2026-08-14

Background

The article summarizes a Schedule 13G beneficial ownership disclosure for Oil-Dri, naming American Century Investment Management, American Century Companies, and the Stowers Institute as reporting persons.

Company-level read

Ticker impact

$ODCNeutralMedium confidence
Context

Oil-Dri reports American Century entities and the Stowers Institute disclosed 5.2% beneficial ownership (527,872 shares) as of 06/30/2026.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven around ownership concentration rather than fundamentals.

Evidence & confidence

The article is a beneficial ownership filing update (Schedule 13G) with no accompanying deal, control change, or company-specific financial guidance.

Market effects

Minimal, as the disclosure does not indicate sector-wide regulatory or demand changes.

None indicated.

None indicated.

Counterpoint

A 5.2% holder can be a passive investor, so the filing may not translate into any governance or strategic change.

Key entities

  • Oil-Dri Corporation of America

    Subject of the Schedule 13G beneficial ownership disclosure.

  • American Century Investment Management, Inc. (ACIM)

    Reports sole voting and dispositive power over 527,872 shares (5.2%).

  • American Century Companies, Inc. (ACC)

    Reports the same 527,872 shares; identified as controlled by the Stowers Institute.

  • Stowers Institute for Medical Research

    Identified as the control entity of ACC for the disclosed stake.

Related articles

$ODCMed

Oil-Dri Corp of America (ODC): Results of Operations and Financial Condition

Oil-Dri Corp of America (ODC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 odcf26q3ex991-earningsrele.htm EX-99.1 Document 410 N. Michigan Ave. Chicago, Illinois 60611, U.S.A News Announcement For Immediate Release Exhibit 99.1 Oil-Dri Reports Record Third Quarter Revenues and Strong Earnings Growth CHICAGO-(June 8, 2026) - Oil-Dri Corporation

$CLMed

Piper Sandler cuts Colgate-Palmolive stock price target on cost pressures

Piper Sandler reduced its price target for Colgate-Palmolive (CL) to $95 from $98, citing cost pressures from elevated oil prices and inventory headwinds. The firm maintained an Overweight rating and a 2026 EPS estimate of $3.85, but lowered its 2027 EPS estimate to $4.12 from $4.23. CL trades at $87.47 with a P/E ratio of 34.6 and a gross profit margin of 60%. Other analysts have maintained positive outlooks, with RBC and UBS setting higher price targets.

$DYMed

KeyBanc raises Dycom Industries stock price target on growth outlook

KeyBanc raised its price target for Dycom Industries (NYSE:DY) to $429 from $423, citing growth outlook and meetings with management. The stock is down 48% from its 52-week high but is considered undervalued. Other analysts have mixed views, with UBS reiterating a Buy rating and Raymond James lowering its target. Dycom reported 38% revenue growth over the last year.

MedAI 8/10

85% of Nscale’s $103B of contracts are with Microsoft and Anthropic

Nscale revealed that 85% of its $103B contracts are with Microsoft (MSFT) and Anthropic, including $43.8B with MSFT and $44.6B with Anthropic. The company acknowledged concentration risk and reported a net loss of $1.02B on $140.6M sales for H1. Nvidia (NVDA) is a major shareholder and supplier. Nscale aims for a $35B valuation in its upcoming IPO.